- Tytuł:
-
Calr type 1/like mutation in
myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant. - Autorzy:
- Temat:
-
MYELOFIBROSIS
GENETIC mutation
LONGEVITY
CLINICAL trials - Źródło:
- Blood Cancer Journal; 3/19/2024, Vol. 14 Issue 1, p1-4, 4p
Czasopismo naukowe